Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Advances in understanding the role of cytokines in inflammatory bowel disease.

Bevivino G, Monteleone G.

Expert Rev Gastroenterol Hepatol. 2018 Jul 19. doi: 10.1080/17474124.2018.1503053. [Epub ahead of print]

PMID:
30024302
2.

RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells.

Rizzo A, Di Giovangiulio M, Stolfi C, Franzè E, Fehling HJ, Carsetti R, Giorda E, Colantoni A, Ortenzi A, Rugge M, Mescoli C, Monteleone G, Fantini MC.

Cancer Immunol Res. 2018 Jul 10. pii: canimm.0698.2017. doi: 10.1158/2326-6066.CIR-17-0698. [Epub ahead of print]

PMID:
29991500
3.

PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report.

Valentini V, Zelli V, Rizzolo P, Silvestri V, Alimandi M, D'Aloia MM, Giustini S, Calvieri S, Richetta AG, Monteleone G, Ottini L.

Clin Case Rep. 2018 Jun 2;6(7):1358-1363. doi: 10.1002/ccr3.1546. eCollection 2018 Jul.

4.

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.

Troncone E, Marafini I, Stolfi C, Monteleone G.

Front Immunol. 2018 Jun 20;9:1407. doi: 10.3389/fimmu.2018.01407. eCollection 2018. Review.

5.

Oligonucleotide-Based Therapies for Inflammatory Bowel Disease.

Bevivino G, Sedda S, Marafini I, Monteleone G.

BioDrugs. 2018 Jun 8. doi: 10.1007/s40259-018-0286-1. [Epub ahead of print] Review.

PMID:
29948918
6.

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.

Laudisi F, Cherubini F, Monteleone G, Stolfi C.

Int J Mol Sci. 2018 Jun 16;19(6). pii: E1787. doi: 10.3390/ijms19061787. Review.

7.

Inflammatory bowel disease: new therapies from antisense oligonucleotides.

Marafini I, Monteleone G.

Ann Med. 2018 Jun 16:1-22. doi: 10.1080/07853890.2018.1490025. [Epub ahead of print]

PMID:
29911450
8.

Internal shoulder impingement in overhead athletes: an ultrasound imaging proposal.

Tramontana A, Monteleone G, Tiloca A, Page JCM.

Ultrasonography. 2018 Jul;37(3):275-276. doi: 10.14366/usg.18008. Epub 2018 Mar 17. No abstract available.

9.

Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study.

Calabrese E, Kucharzik T, Maaser C, Maconi G, Strobel D, Wilson SR, Zorzi F, Novak KL, Bruining DH, Iacucci M, Watanabe M, Lolli E, Chiaramonte C, Hanauer SB, Panaccione R, Pallone F, Ghosh S, Monteleone G.

Inflamm Bowel Dis. 2018 Apr 28. doi: 10.1093/ibd/izy091. [Epub ahead of print]

PMID:
29718450
10.

The pedicle instrumentation and percutaneous elevation (Pi.Pe): a new cementless surgical technique in type A post-traumatic vertebral fractures.

Piazzolla A, Solarino G, Bizzoca D, Parato C, Monteleone G, Dicuonzo F, Moretti B.

Eur Spine J. 2018 Jun;27(Suppl 2):182-189. doi: 10.1007/s00586-018-5602-4. Epub 2018 Apr 20.

PMID:
29679136
11.

Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.

Izzo R, Bevivino G, De Simone V, Sedda S, Monteleone I, Marafini I, Di Giovangiulio M, Rizzo A, Franzè E, Colantoni A, Ortenzi A, Monteleone G.

Inflamm Bowel Dis. 2018 May 18;24(6):1213-1224. doi: 10.1093/ibd/izy062.

PMID:
29668937
12.

Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.

Di Fusco D, Dinallo V, Monteleone I, Laudisi F, Marafini I, Franzè E, Di Grazia A, Dwairi R, Colantoni A, Ortenzi A, Stolfi C, Monteleone G.

Clin Sci (Lond). 2018 Jun 12;132(11):1155-1168. doi: 10.1042/CS20180167. Print 2018 Jun 15.

PMID:
29540537
14.

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.

Franzè E, Dinallo V, Rizzo A, Di Giovangiulio M, Bevivino G, Stolfi C, Caprioli F, Colantoni A, Ortenzi A, Grazia AD, Sica G, Sileri PP, Rossi P, Monteleone G.

Oncotarget. 2017 Dec 15;9(3):3432-3445. doi: 10.18632/oncotarget.23289. eCollection 2018 Jan 9.

15.

High SMAD7 and p-SMAD2,3 expression is associated with environmental enteropathy in children.

Syed S, Dinallo V, Iqbal NT, Di Iorio L, Di Fusco D, Guleria S, Amadi BC, Sadiq K, Moskaluk C, Ali SA, Kelly P, Monteleone G.

PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006224. doi: 10.1371/journal.pntd.0006224. eCollection 2018 Feb.

16.

Spatio-temporal dynamics of the mirror neuron system during social intentions.

Cacioppo S, Bolmont M, Monteleone G.

Soc Neurosci. 2017 Oct 27:1-21. doi: 10.1080/17470919.2017.1394911. [Epub ahead of print]

PMID:
29048247
17.

Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?

Fantini MC, Monteleone G.

Inflamm Bowel Dis. 2017 Oct;23(10):1682-1688. doi: 10.1097/MIB.0000000000001272. Review.

PMID:
28906289
18.

Predicting Intentions of a Familiar Significant Other Beyond the Mirror Neuron System.

Cacioppo S, Juan E, Monteleone G.

Front Behav Neurosci. 2017 Aug 25;11:155. doi: 10.3389/fnbeh.2017.00155. eCollection 2017.

19.

Immunomodulatory properties of Olea europaea leaf extract in intestinal inflammation.

Vezza T, Algieri F, Rodríguez-Nogales A, Garrido-Mesa J, Utrilla MP, Talhaoui N, Gómez-Caravaca AM, Segura-Carretero A, Rodríguez-Cabezas ME, Monteleone G, Gálvez J.

Mol Nutr Food Res. 2017 Oct;61(10). doi: 10.1002/mnfr.201601066. Epub 2017 Aug 29.

PMID:
28731213
20.

The safety of non-biological treatments in Ulcerative Colitis.

Troncone E, Monteleone G.

Expert Opin Drug Saf. 2017 Jul;16(7):779-789. doi: 10.1080/14740338.2017.1340936. Epub 2017 Jun 19. Review.

PMID:
28608717
21.

Smad7 positively regulates keratinocyte proliferation in psoriasis.

Di Fusco D, Laudisi F, Dinallo V, Monteleone I, Di Grazia A, Marafini I, Troncone E, Colantoni A, Ortenzi A, Stolfi C, Picardo M, Monteleone G.

Br J Dermatol. 2017 Dec;177(6):1633-1643. doi: 10.1111/bjd.15703. Epub 2017 Nov 16.

PMID:
28580633
22.

CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide.

Marafini I, Monteleone I, Dinallo V, Di Fusco D, De Simone V, Laudisi F, Fantini MC, Di Sabatino A, Pallone F, Monteleone G.

J Crohns Colitis. 2017 May 1;11(5):603-609. doi: 10.1093/ecco-jcc/jjw191.

PMID:
28453765
23.

Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium.

Vanoli A, Di Sabatino A, Furlan D, Klersy C, Grillo F, Fiocca R, Mescoli C, Rugge M, Nesi G, Fociani P, Sampietro G, Ardizzone S, Luinetti O, Calabrò A, Tonelli F, Volta U, Santini D, Caio G, Giuffrida P, Elli L, Ferrero S, Latella G, Ciardi A, Caronna R, Solina G, Rizzo A, Ciacci C, D'Armiento FP, Salemme M, Villanacci V, Cannizzaro R, Canzonieri V, Reggiani Bonetti L, Biancone L, Monteleone G, Orlandi A, Santeusanio G, Macciomei MC, D'Incà R, Perfetti V, Sandri G, Silano M, Florena AM, Giannone AG, Papi C, Coppola L, Usai P, Maccioni A, Astegiano M, Migliora P, Manca R, Martino M, Trapani D, Cerutti R, Alberizzi P, Riboni R, Sessa F, Paulli M, Solcia E, Corazza GR.

J Crohns Colitis. 2017 Aug 1;11(8):942-953. doi: 10.1093/ecco-jcc/jjx031.

PMID:
28333239
24.

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death.

De Simone V, Bevivino G, Sedda S, Izzo R, Laudisi F, Dinallo V, Franzè E, Colantoni A, Ortenzi A, Salvatori S, Rossi P, Sica GS, Fantini MC, Stolfi C, Monteleone G.

Cell Death Dis. 2017 Mar 16;8(3):e2681. doi: 10.1038/cddis.2017.103.

25.

Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis.

Franchi L, Monteleone I, Hao LY, Spahr MA, Zhao W, Liu X, Demock K, Kulkarni A, Lesch CA, Sanchez B, Carter L, Marafini I, Hu X, Mashadova O, Yuan M, Asara JM, Singh H, Lyssiotis CA, Monteleone G, Opipari AW, Glick GD.

J Immunol. 2017 Apr 1;198(7):2735-2746. doi: 10.4049/jimmunol.1600810. Epub 2017 Feb 27.

26.

Radioguided Occult Lesion Localization in Deep Schwannomas of the Peripheral Nerves: Results of a Preliminary Case Series.

Stevanato G, Monteleone G, Sgubin D, Sicolo M, Pastorello G, Vazzana L, Guida F.

Acta Neurochir Suppl. 2017;124:315-318. doi: 10.1007/978-3-319-39546-3_46.

PMID:
28120090
27.

Antiprotozoal Activity-Based Profiling of a Dichloromethane Extract from Anthemis nobilis Flowers.

De Mieri M, Monteleone G, Ismajili I, Kaiser M, Hamburger M.

J Nat Prod. 2017 Feb 24;80(2):459-470. doi: 10.1021/acs.jnatprod.6b00980. Epub 2017 Jan 24.

PMID:
28116906
28.

Corrigendum: No Change in the Mucosal Gut Microbiome is Associated with Celiac Disease-Specific Microbiome Alteration in Adult Patients.

D'Argenio V, Casaburi G, Precone V, Pagliuca C, Colicchio R, Sarnataro D, Discepolo V, Kim SM, Russo I, Del Vecchio Blanco G, Horner DS, Chiara M, Pesole G, Salvatore P, Monteleone G, Ciacci C, Caporaso GJ, Jabrì B, Salvatore F, Sacchetti L.

Am J Gastroenterol. 2017 Jan;112(1):193. doi: 10.1038/ajg.2016.561. Epub 2016 Dec 13. No abstract available.

PMID:
27958280
29.

High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.

Sedda S, De Simone V, Marafini I, Bevivino G, Izzo R, Paoluzi OA, Colantoni A, Ortenzi A, Giuffrida P, Corazza GR, Vanoli A, Di Sabatino A, Pallone F, Monteleone G.

Immunology. 2017 Mar;150(3):356-363. doi: 10.1111/imm.12690. Epub 2016 Dec 12.

30.

Entrapment of the sciatic nerve at the linea aspera: A case report and literature review.

Monteleone G, Stevanato G.

Surg Neurol Int. 2016 Oct 19;7:89. eCollection 2016.

31.

No Change in the Mucosal Gut Microbiome is Associated With Celiac Disease-Specific Microbiome Alteration in Adult Patients.

D'Argenio V, Casaburi G, Precone V, Pagliuca C, Colicchio R, Sarnataro D, Discepolo V, Kim SM, Russo I, Del Vecchio Blanco G, Horner DS, Chiara M, Pesole G, Salvatore P, Monteleone G, Ciacci C, Caporaso GJ, Jabrì B, Salvatore F, Sacchetti L.

Am J Gastroenterol. 2016 Nov;111(11):1659-1661. doi: 10.1038/ajg.2016.227. No abstract available.

PMID:
27808136
32.

Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis.

Triggianese P, Conigliaro P, Chimenti MS, Biancone L, Monteleone G, Perricone R, Monteleone I.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1085-1093. Epub 2016 Oct 21.

PMID:
27782868
33.

The gut-skin axis in health and disease: A paradigm with therapeutic implications.

O'Neill CA, Monteleone G, McLaughlin JT, Paus R.

Bioessays. 2016 Nov;38(11):1167-1176. doi: 10.1002/bies.201600008. Epub 2016 Aug 24. Review.

PMID:
27554239
34.

Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis.

Izzo R, Figliuzzi MM, Monteleone G.

Expert Rev Clin Immunol. 2016 Nov;12(11):1137-1139. Epub 2016 Aug 8. No abstract available.

PMID:
27494562
35.

A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.

Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, Menghini R, Federici M.

Cell Rep. 2016 Aug 23;16(8):2269. doi: 10.1016/j.celrep.2016.07.078. Epub 2016 Aug 29. No abstract available.

36.

Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice.

Monteleone I, Marafini I, Dinallo V, Di Fusco D, Troncone E, Zorzi F, Laudisi F, Monteleone G.

J Crohns Colitis. 2017 Feb;11(2):237-245. doi: 10.1093/ecco-jcc/jjw139. Epub 2016 Jul 29.

PMID:
27473029
37.

A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.

Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, Menghini R, Federici M.

Cell Rep. 2016 Jul 19;16(3):731-43. doi: 10.1016/j.celrep.2016.06.027. Epub 2016 Jun 30. Erratum in: Cell Rep. 2016 Aug 23;16(8):2269.

38.

Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease.

Ardizzone S, Bevivino G, Monteleone G.

Therap Adv Gastroenterol. 2016 Jul;9(4):527-32. doi: 10.1177/1756283X16636781. Epub 2016 Mar 15. Review.

39.

Tofacitinib for the treatment of ulcerative colitis.

Izzo R, Bevivino G, Monteleone G.

Expert Opin Investig Drugs. 2016 Aug;25(8):991-7. doi: 10.1080/13543784.2016.1189900. Epub 2016 May 30. Review.

PMID:
27177233
40.

Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells.

Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi ML, Fina D, Paoluzi AO, Pallone F, Monteleone G.

PLoS One. 2016 May 12;11(5):e0155103. doi: 10.1371/journal.pone.0155103. eCollection 2016.

41.

Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study.

Camporese G, Bernardi E, Noventa F, Bosco M, Monteleone G, Santoro L, Bortoluzzi C, Freguja S, Nardin M, Marullo M, Zanon G, Mazzola C, Damiani G, Maniscalco P, Imberti D, Lodigiani C, Becattini C, Tonello C, Agnelli G; ERIKA Study Group.

Thromb Haemost. 2016 Aug 1;116(2):349-55. doi: 10.1160/TH16-02-0118. Epub 2016 Apr 14.

PMID:
27075710
42.

Metagenomics Reveals Dysbiosis and a Potentially Pathogenic N. flavescens Strain in Duodenum of Adult Celiac Patients.

D'Argenio V, Casaburi G, Precone V, Pagliuca C, Colicchio R, Sarnataro D, Discepolo V, Kim SM, Russo I, Del Vecchio Blanco G, Horner DS, Chiara M, Pesole G, Salvatore P, Monteleone G, Ciacci C, Caporaso GJ, Jabrì B, Salvatore F, Sacchetti L.

Am J Gastroenterol. 2016 Jun;111(6):879-90. doi: 10.1038/ajg.2016.95. Epub 2016 Apr 5.

43.

Therapy implications for the role of IL-21 in lupus.

Dinallo V, Di Fusco D, Izzo R, Monteleone G.

Expert Rev Clin Immunol. 2016;12(5):487-8. doi: 10.1586/1744666X.2016.1152183. Epub 2016 Feb 24. No abstract available.

PMID:
26854362
44.

Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut.

Monteleone I, Marafini I, Zorzi F, Di Fusco D, Dinallo V, Rizzo A, Sileri P, Sica G, Monteleone G.

J Crohns Colitis. 2016 Jun;10(6):670-7. doi: 10.1093/ecco-jcc/jjw030. Epub 2016 Jan 27.

PMID:
26818761
45.

Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut.

Monteleone I, Zorzi F, Marafini I, Di Fusco D, Dinallo V, Caruso R, Izzo R, Franzè E, Colantoni A, Pallone F, Monteleone G.

Eur J Immunol. 2016 Apr;46(4):1047-57. doi: 10.1002/eji.201445228. Epub 2016 Feb 5.

46.

Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease.

Monteleone G, Di Sabatino A, Ardizzone S, Pallone F, Usiskin K, Zhan X, Rossiter G, Neurath MF.

Aliment Pharmacol Ther. 2016 Mar;43(6):717-24. doi: 10.1111/apt.13526. Epub 2016 Jan 13.

47.

Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.

Laudisi F, Dinallo V, Di Fusco D, Monteleone G.

Curr Drug Metab. 2016;17(3):303-6. Review.

PMID:
26651974
48.

Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.

Zorzi F, Calabrese E, Monteleone G.

Clin Sci (Lond). 2015 Dec;129(12):1107-13. doi: 10.1042/CS20150472. Review.

PMID:
26494636
49.

Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells.

Franzè E, Marafini I, De Simone V, Monteleone I, Caprioli F, Colantoni A, Ortenzi A, Crescenzi F, Izzo R, Sica G, Sileri P, Rossi P, Pallone F, Monteleone G.

J Crohns Colitis. 2016 Jan;10(1):87-94. doi: 10.1093/ecco-jcc/jjv181. Epub 2015 Oct 8.

PMID:
26449789
50.

The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man.

Marafini I, Angelucci E, Pallone F, Monteleone G.

Dig Dis. 2015 Sep 14;33 Suppl 1:113-119. [Epub ahead of print]

PMID:
26366705

Supplemental Content

Loading ...
Support Center